期刊文献+

绿色荧光蛋白-小鼠纤维介素蛋白融合基因表达载体的构建和表达 被引量:4

Construction and characterization of GFP-mfgl 2 fusion protein expression plasmid
下载PDF
导出
摘要 目的:构建绿色荧光蛋白(GFP)和小鼠纤维介素蛋白(mfgl2)的融合蛋白表达载体,在仓鼠卵巢(CHO)细胞中表达,为mfgl2的RNA干扰体外研究提供简便的判断手段。方法:用PCR从mfgl2cDNA文库中扩增出mfgl2cDNA片段,插入到GFP表达载体pEGFP N2中GFP基因序列的上游,构建成GFP mfgl2融合基因表达载体pEGFP mfgl2,将该载体转染到CHO细胞后24~48h,通过荧光显微镜观察并摄片。结果:扩增出长约1.3kb的基因片段,经双酶切鉴定和测序鉴定无误;重组载体转染CHO细胞后,在荧光显微镜下可观察到GFP的表达。结论:成功构建了pEGFP mfgl2融合基因表达载体;重组载体可在CHO细胞中表达出GFP mfgl2融合蛋白,为下一步进行mfgl2RNA干扰研究提供了简便的判断手段。 Objective: To construct and characterize GFP-mfgl 2 fusion protein expression plasmid (pEGFP-mfgl 2) and provide a direct and simplified methodology for primary assessment of the effect of mfgl 2 siRNA on the mfgl 2 gene expression. Methods: mfgl 2 cDNA was amplified from the mfgl 2 cDNA library pBluescript-m166 (pm166) of mouse genomic P1 plasmid and recloned into pEGFP-N2 upstream of GFP gene. The pEGFP-mfgl 2 was analyzed by restriction endonucleases BamH I and Hind III to ensure the orientation and the sequence. This fusion plasmid was then transfected into CHO cells and the fusion protein expression was observed by fluorescent microscope. Rusults: A 1.3 kb long cDNA was obtained. Restriction endonucleases and sequencing assays showed the correct orientation and sequence. After 24-48 hours transfection in CHO cells, the expression of pEGFP-mfgl 2 can be visualized through fluorescent microscope. Conclusion: pEGFP mfgl 2 has been constructed successfully. The recombinant vector can express GFP-mfgl 2 fusion protein. It provides a direct and simplified methodology for primary assessment of the effect of mfgl 2 siRNA on the mfgl 2 gene expression.
作者 汪之沫 宁琴
出处 《医学研究生学报》 CAS 2005年第4期289-291,F003,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30170846) 武汉市科技局攻关基金资助项目(批准号:20027006144)
关键词 纤维介素蛋白 绿色荧光蛋白 融合蛋白 Fibrinogen-like protein 2 Green fluorescent protein Fusion protein
  • 相关文献

参考文献11

  • 1Prasher DC, Eckenrode VK, Ward WW et al. Primary structure of the Aequorea victoria green-fluorescent protein[J]. Gene, 1992, 111(2):229-233.
  • 2Heim R, Tsien RY. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer[J]. Curr Biol, 1996, 6(2):178-182.
  • 3Shen ZX, Chen GQ, Ni JH et al. Use of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL): clinical efficacy and pharmacokinetics in relapsed patients[J]. Blood, 1997, 89(9): 3354-3360.
  • 4Puccetti E, Guller S, Orleth A et al. Bcr-Abl mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity[J]. Cancer Res, 2000, 60(13): 3409-3413.
  • 5Chalfie M, Tu Y, Euskirchen G et al. Green fluorescent protein as a marker for gene expression[J]. Science, 1994, 263(5148): 802-805.
  • 6Levy GA, Liu MF, Ding JW et al. Molecular and functional analysis of the human prothrombinase gene(hfgl 2) and its role in viral hepatitis[J]. Am J Pathol, 2000, 156(4): 1217-1225.
  • 7Yuwaraj S, Ding JW, Liu MF et al. Genomic characterization, localization, and functional expression of fgl 2, the human gene encoding fibroleukin: a novel human procoagulant[J]. Genomics, 2001, 71(3): 330-338.
  • 8Marsden PA, Ning Q, Fung LS et al. The fgl 2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis[J]. J Clin Invest, 2003, 112(1):58-66.
  • 9孙奕,宁琴,李锦文,严伟明,陈忠华,龚非力.鼠纤维介素在小鼠心脏移植急性排斥反应中的表达及其意义[J].中华器官移植杂志,2003,24(5):294-297. 被引量:27
  • 10张莉,宁琴,郭晖,张伟杰,陈芳,罗小平.人纤维介素在急性排斥反应时移植肾组织中的表达及意义[J].中华医学杂志,2004,84(6):474-477. 被引量:12

二级参考文献14

  • 1王泊沅 李玉松 黄高升 主编.病理学技术[M].北京:人民卫生出版社,2000.415-416,420.
  • 2Clark DA, Ding JM, Chaouat G, et al. The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol, 1999, 42:37-43.
  • 3Ding JW, Ning Q, Liu MF, et al. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol, 1998, 440:609-618.
  • 4Levy GA, Marsden R, Zhong EH, et al. Strategies to prevent thrombosis in xenotransplants. Transplant Proc, 1998, 30: 2458-2460.
  • 5Yuwaraj S, Ding J, Liu M, et al. Genomic characterization,localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant.Genomics,2001, 71:330-338.
  • 6Levy GA, Liu MF, Ding JW, et al. Molecular and functional analysis of the human prothrombinases gene(HFGL2)and its role in viral hepatitis. Am J Pathology, 2000, 156:1217-1224.
  • 7Ning Q, Kongkham P, Liu MF. Nucleocapsid gene of murine hepatitis virus strain 3 ( MHV-3 ) induces transcription of the fg12 prothrombinase gene. J Biol Chem, 1999, 274:9930-9936.
  • 8Levy GA, Ding JW, Weiner D. The role of fibrinogen like protein(fgl2/fibroleukin) in xenogrraft rejection:indution of fg12 prothrombinase by xenoserum. Hepatology, 1999, 30:109.
  • 9Chen ZH. A technique of cervical heterotopic heart transplantation in mice. Transplantation, 1991, 52:1099.
  • 10Billingham ME, Cary NRB, Hammond EH, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant, 1990, 9:587.

共引文献32

同被引文献30

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部